Get started
Author

Karin Boman

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer – Results from two randomised studies
2010 · Thomas Hogberg, Mauro Signorelli, et al. · European Journal of Cancer · 448
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
2018 · Ignace Vergote, Corneel Coens, et al. · The Lancet Oncology · 331
PDF
Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a
2006 · Lian Liu, Singareddy Rajareddy, et al. · Development · 254
Control of mammalian oocyte growth and early follicular development by the oocyte PI3 kinase pathway: New roles for an old timer
2006 · Kui Liu, Singareddy Rajareddy, et al. · Developmental Biology · 228
Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development
2005 · Pradeep Reddy, Lijun Shen, et al. · Developmental Biology · 192
PDF
External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma—A Prospective Randomized Study
2011 · Bengt Sorbe, György Horvath, et al. · International Journal of Radiation Oncology*Biology*Physics · 160
Formation of E-Cadherin-Mediated Cell-Cell Adhesion Activates Akt and Mitogen Activated Protein Kinase via Phosphatidylinositol 3 Kinase and Ligand-Independent Activation of Epidermal Growth Factor Receptor in Ovarian Cancer Cells
2005 · Pradeep Reddy, Lian Liu, et al. · Molecular Endocrinology · 139
PDF
Randomized Trial of Single Agent Paclitaxel Given Weekly Versus Every Three Weeks and with Peroral Versus Intravenous Steroid Premedication to Patients with Ovarian Cancer Previously Treated with Platinum
2002 · Per Rosenberg, Ha˚kan Andersson, et al. · Acta Oncologica · 136
PDF
Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxellong-term follow-up
2007 · B. SORBE, H. ANDERSSON, et al. · International Journal of Gynecological Cancer · 83
Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial
2011 · Florence Joly, Isabelle Ray-Coquard, et al. · Gynecologic Oncology · 71
Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer
2009 · J.M. Del Campo, A. Roszak, et al. · Annals of Oncology · 65
PDF
External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma
2012 · Bengt Göran Sorbe, György Horvath, et al. · International Journal of Gynecological Cancer · 56
Phosphorylation and inactivation of glycogen synthase kinase-3 by soluble kit ligand in mouse oocytes during early follicular development
2007 · Lian Liu, Singareddy Rajareddy, et al. · Journal of Molecular Endocrinology · 46
PDF
A Systematic Overview of Radiation Therapy Effects in Cervical Cancer (Cervix Uteri)
2003 · Nina Einhorn†, Claes Tropé, et al. · Acta Oncologica · 44
PDF
Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)
2014 · Kristina Lindemann, Susanne Malander, et al. · BMC Cancer · 41
PDF
A Systematic Overview of Radiation Therapy Effects in Ovarian Cancer
2003 · Nina Einhorn†, Claes Tropé, et al. · Acta Oncologica · 38
PDF
Immunohistochemical study of the human 17β‐hydroxysteroid dehydrogenase and steroid receptors in endometrial adenocarcinoma
1992 · Olli Mäentausta, Karin Boman, et al. · Cancer · 36
Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study
2011 · Thomas J. Herzog, Jan B. Vermorken, et al. · Gynecologic Oncology · 26
A Systematic Overview of Radiation Therapy Effects in Uterine Cancer (Corpus Uteri)
2003 · Nina Einhorn†, Claes Tropé, et al. · Acta Oncologica · 24
PDF
Long-term results from a phase II study of single agent paclitaxel (Taxol®) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience
1998 · C. Tropé, Th. Hogberg, et al. · Annals of Oncology · 22
A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis
1998 · Bengt G. Sorbe, Anne-Marie Berglind, et al. · Cancer · 19
Phase II open label randomized study of trabectedin (T) given as two different dosing schedules in women with platinum-sensitive, recurrent ovarian carcinoma: Preliminary results
2006 · J. Del Campo, A. Roszak, et al. · Journal of Clinical Oncology · 13
Apoptosis, proliferation, and hormone receptors in endometrial carcinoma: Results depending on methods of analysis
2003 · M. Dahmoun, T. Bäckström, et al. · International Journal of Oncology · 13
Oestrogens and clinical characteristics in endometrial carcinoma.
1990 · K Boman, T Bäckström, et al. · PubMed · 8
Paclitaxel-carboplatin-gemcitabine (TCG) as first-line treatment of ovarian cancer: a prospective multicenter phase II study (AGO-OVAR 8) followed by a prospectively randomized phase III GCIG Intergroup study (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102) comparing TCG with standard TC
2005 · A. BOIS, J. SEHOULI, et al. · International Journal of Gynecological Cancer · 7
Works count: 43
Citation count: 2,524
H-index: 20
I10-index: 23
Year
Topic
Type